UCM
Health Care Equipment & Services
Uscom
- Short interest
- 0.01%
- 0.00 pp 30d
- as of 1 Oct 2020
- Reported shorts
- 19.1K
- Shares on issue
- 150.513M
Uscom (UCM) financials
Results, ratios and statements
Latest result
12 months to 31 Dec 2025 (TTM Dec 25), figures in AUD, the reporting currency
- Revenue
- $1.6Mvs n/a
- Yahoo Finance, as at 14 Oct 2026
- NPAT
- −$1.3Mvs n/a
- Yahoo Finance, as at 14 Oct 2026
- EPS (diluted)
- −$0.007vs n/a
- Yahoo Finance, as at 14 Oct 2026
- Rev YoY
- −29.9%FY
- EPS YoY
- n/aFY
Key ratios
12 months to 31 Dec 2025 (TTM); no balance sheet aligned with this period; prices to 14 Oct 2026
- Gross margin
- 86.9%
- Operating margin
- −165.6%
- Net margin
- −78.4%
- FCF margin
- −173.0%
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- −12.2×
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | TTM Dec 25 | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|---|
| Revenue | $1.6M | $2.6MM (source: ASX (Markit)) | $3.7M | $2.7M | $2.5M |
| Gross profit | $1.4M | n/a | $3.1M | $2.2M | $2.2M |
| Operating income | −$2.7M | n/a | −$2.4M | −$2.9M | −$2.6M |
| EBITDA | −$68.1K | n/a | −$1.5M | −$2.1M | −$1.4M |
| EBIT | −$375.7K | n/a | −$1.9M | −$2.5M | −$1.9M |
| Interest expense | $223.7K | n/a | $131.5K | $102.9K | $78.7K |
| Pretax income | −$599.4K | n/a | −$2.0M | −$2.6M | −$1.9M |
| Tax | $26.7K | n/a | $47.4K | $34.3K | $32.4K |
| NPAT | −$1.3M | −$3.3MM (source: ASX (Markit)) | −$2.1M | −$2.6M | −$2.0M |
| Net interest income | −$211.9K | n/a | −$85.5K | −$47.5K | −$55.3K |
| EPS basic | −$0.007 | n/a | −$0.012 | −$0.015 | −$0.011 |
| EPS diluted | −$0.007 | n/a | −$0.012 | −$0.015 | −$0.011 |
| Shares | n/a | n/a | 244.6M | 187.4M | 196.8M |
- ASX (Markit)
Financial reports
The company's own filings, newest first
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report28 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report28 Jul 2026via asx_announcements
- Quarterly Appendix 4C Cash Flow ReportQuarterly Report15 Jun 2026via asx_announcements
- Quarterly Appendix 4C Cash Flow ReportQuarterly Report8 Apr 2026via asx_announcements
- Half Yearly Report and AccountsHalf Year Results27 Feb 2026via asx_announcements
- Quarterly Appendix 4C Cash Flow ReportQuarterly Report30 Jan 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Oct 2025via asx_announcements
- Annual Report to shareholdersAnnual Report26 Sep 2025via asx_announcements
- Preliminary Final ReportAnnual Results29 Aug 2025via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Jul 2025via asx_announcements
Showing 10 of 76 reports